Attachment
Gates Package, p.1326 · gates:exh:00613
Page text: p.1326 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
EXAMPLES OF PREVIOUS WORK IN THESE AREAS
CAPABILITIES
CONCEIVE
CREATE
CARRY THROUGH
*
85+ investments across the Accelerators
*
Multiple companies launched after
*
Syndicates: Multiple leveraged funding
portfolio from 2016-2022
receiving grants from the Accelerator
partnerships across both commercial
and government entities
'Sample Partners
Select Examples
.
.
G55 university
*
Government incentives: BMGF
York. Ub NOVARTIS
@ ensoma
experience starting GAVI
we
most
Gene therapy
Se
Ibi Oster:
Raise $70M in Series A
th NovarRTIS
Seattle Children's
lo
Hospital
°
Uni every
chilis
we
Gene-based cure for sickle cell disease
Ody
ge
NIR &
Gifs
FRED HUTCH
~
Significant 1:1 leveraged funding
te CURES START HERETM
Parte
een
A
Engineering B cells
.
&
=
Raised $52M in Series A
Collaboration on gene-based cures
THERAPEUTICS
for
HIV and sickle cell disease
EMORY Levers
Cw
$100M ou) funding
Engineering B cells
Org development for vaccine distribution
+) And many more
Raised $50M and $73M in
$5.8B in grant funding from BMGF
Series A funding
committed to date
Gf
Not for distribution